There are no products listed under this category.
ARHGAP11A
ARHGAP11A (Rho GTPase activating protein 11A, also known as KIAA0013) is a nuclear member of the Rho GTPase-activating protein family. It switches Rho-type GTPases into their inactive GDP-bound state and, after DNA damage, interacts with p53. Browse Assay Genie's current range of ARHGAP11A research reagents below, or read on for the biology behind the target.
ARHGAP11A is a GTPase activator for the Rho-type GTPases. It converts them to an inactive GDP-bound state, which places it among the negative regulators of Rho signalling. The protein is located in the nucleus. HGNC classifies the gene within the Rho GTPase activating proteins group.
According to the NCBI Gene summary, the ARHGAP11A protein has a role in the DNA damage response. After DNA damage it interacts with the p53 tumour suppressor protein and stimulates its tetramerisation. This results in cell-cycle arrest and apoptosis. Studies of the ARHGAP11A gene and protein are therefore relevant to p53 biology as well as to Rho GTPase regulation.
The gene is highly expressed in colon cancers and in a human basal-like breast cancer cell line. A chromosomal deletion that includes the gene is one cause of Prader-Willi syndrome, and an intronic variant may be associated with sleep duration in children. The locus also produces an ARHGAP11A-SCG5 readthrough transcript and the corresponding ARHGAP11A-SCG5 protein. The older alias KIAA0013 is still found in the literature, and the mouse ortholog is Arhgap11a.
ARHGAP11A interacts with p53 after DNA damage and stimulates its tetramerisation, leading to cell-cycle arrest and apoptosis.
As a GTPase activator, it converts Rho-type GTPases to the inactive GDP-bound state, making it a regulator of Rho pathway activity.
High expression in colon cancers and in a human basal-like breast cancer cell line makes ARHGAP11A a subject of tumour research.
A chromosomal deletion including this gene is one cause of Prader-Willi syndrome, and an intronic variant may be linked to sleep duration in children.
ARHGAP11A is a GTPase activator for Rho-type GTPases, converting them to an inactive GDP-bound state. After DNA damage it also interacts with the p53 tumour suppressor and stimulates its tetramerisation, which results in cell-cycle arrest and apoptosis.
KIAA0013 is an alias of ARHGAP11A. The gene also produces an ARHGAP11A-SCG5 readthrough transcript and the corresponding ARHGAP11A-SCG5 protein, so researchers should check which product a reagent is directed against. Check the datasheet of any product for its validated reactivity.
A chromosomal deletion that includes the ARHGAP11A gene is one cause of Prader-Willi syndrome, and an intronic variant may be associated with sleep duration in children. The gene is highly expressed in colon cancers and in a human basal-like breast cancer cell line. The mouse ortholog is Arhgap11a.
Other Rho GTPase-activating proteins that regulate Rho-family signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q6P4F7; product specifications from Assay Genie datasheets.
There are no products listed under this category.